p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
Cancer metastasis reviews
p66Shc, a 66 kDa proto-oncogene Src homologous-collagen homologue (Shc) adaptor protein, is classically known in mediating receptor tyrosine kinase signaling and recently identified as a sensor to oxidative stress-induced apoptosis and as a longevity protein in mammals. The expression of p66Shc is decreased in mice and increased in human fibroblasts upon aging and in aging-related diseases, including prostate cancer. p66Shc protein level correlates with the proliferation of several carcinoma cells and can be regulated by steroid hormones. Recent advances point that p66Shc protein plays a role in mediating cross-talk between steroid hormones and redox signals by serving as a common convergence point in signaling pathways on cell proliferation and apoptosis. This article first reviews the unique function of p66Shc protein in regulating oxidative stress-induced apoptosis. Subsequently, we discuss its novel role in androgen-regulated prostate cancer cell proliferation and metastasis and the mechanism by which it mediates androgen action via the redox signaling pathway. The data together indicate that p66Shc might be a useful biomarker for the prognosis of prostate cancer and serve as an effective target for its cancer treatment.
Animals, Carcinoma, Disease Progression, Humans, Longevity, Male, Mice, Models, Biological, Neoplasm Metastasis, Oxidation-Reduction, Prognosis, Prostatic Neoplasms, Shc Signaling Adaptor Proteins
Rajendran, Mythilypriya; Thomes, Paul; Zhang, Li; Veeramani, Suresh; and Lin, Ming-Fong, "p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis." (2010). Journal Articles: Biochemistry & Molecular Biology. 40.
The final publication is available at Springer via http://dx.doi.org/10.1007/s10555-010-9213-8